WFIKKN1
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1
Also known as: C16orf12, RJD2, WFDC20A, WFIKKN, WFKN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96NZ8
- Gene
- WFIKKN1
- Ensembl
- ENSG00000127578
- Chromosome
- 16
- Canonical length
- 548 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene encodes a secreted multidomain protein consisting of a signal peptide, a WAP domain, a follistatin domain, an immunoglobulin domain, two tandem Kunitz domains, and an NTR domain. These domains have been implicated frequently in inhibition of various types of proteases, suggesting that the encoded protein may be a multivalent protease inhibitor and may control the action of multiple types of serine proteases as well as metalloproteinases. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
548 residues, UniProt reviewed canonical sequence.
>Q96NZ8|WFIKKN1
1 MPALRPLLPL LLLLRLTSGA GLLPGLGSHP GVCPNQLSPN LWVDAQSTCE RECSRDQDCA
61 AAEKCCINVC GLHSCVAARF PGSPAAPTTA ASCEGFVCPQ QGSDCDIWDG QPVCRCRDRC
121 EKEPSFTCAS DGLTYYNRCY MDAEACLRGL HLHIVPCKHV LSWPPSSPGP PETTARPTPG
181 AAPVPPALYS SPSPQAVQVG GTASLHCDVS GRPPPAVTWE KQSHQRENLI MRPDQMYGNV
241 VVTSIGQLVL YNARPEDAGL YTCTARNAAG LLRADFPLSV VQREPARDAA PSIPAPAECL
301 PDVQACTGPT SPHLVLWHYD PQRGGCMTFP ARGCDGAARG FETYEACQQA CARGPGDACV
361 LPAVQGPCRG WEPRWAYSPL LQQCHPFVYG GCEGNGNNFH SRESCEDACP VPRTPPCRAC
421 RLRSKLALSL CRSDFAIVGR LTEVLEEPEA AGGIARVALE DVLKDDKMGL KFLGTKYLEV
481 TLSGMDWACP CPNMTAGDGP LVIMGEVRDG VAVLDAGSYV RAASEKRVKK ILELLEKQAC
541 ELLNRFQDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against WFIKKN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 5 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 5 nTPM
- kidney: 2.1 nTPM
- basal ganglia: 1.8 nTPM
- cerebral cortex: 1.8 nTPM
- amygdala: 1.4 nTPM
- pituitary gland: 1.4 nTPM
Single-cell type
- thymic myoid cells: 14 nCPM
- medullary thymic epithelial cells: 9.6 nCPM
- retinal horizontal cells: 8 nCPM
- foveolar cells: 6 nCPM
- respiratory ionocytes: 5.1 nCPM
- gonadotrophs: 4.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 4.3 nTPM
- cerebral cortex: 2.7 nTPM
- white matter: 2.1 nTPM
- basal ganglia: 1.8 nTPM
- amygdala: 1.6 nTPM
- hippocampal formation: 1.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.45
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- muscle cell development
- negative regulation of transforming growth factor beta receptor signaling pathway
- roof of mouth development
- skeletal system development
- transforming growth factor beta receptor signaling pathway
Molecular functions
- receptor antagonist activity
- serine-type endopeptidase inhibitor activity
- transforming growth factor beta binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Netrin domain
- Pancreatic trypsin inhibitor Kunitz domain
- Kazal domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- WAP-type 'four-disulfide core' domain
- Tissue inhibitor of metalloproteinases-like, OB-fold
- Immunoglobulin-like fold
- Proteinase inhibitor I2, Kunitz, conserved site
- WFIKKN1/2, immunoglobulin-like domain 3
- Kazal domain superfamily
- Immunoglobulin-like domain superfamily
- Elafin-like superfamily
- Pancreatic trypsin inhibitor Kunitz domain superfamily
- Kunitz/Bovine pancreatic trypsin inhibitor domain
- WAP-type (Whey Acidic Protein) 'four-disulfide core'
- Immunoglobulin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads WFIKKN1 as an antibody target. Whether an autoantibody or antibody against WFIKKN1 could matter depends on whether native WFIKKN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
WFIKKN1 is annotated as secreted, so native WFIKKN1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label WFIKKN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...